RAM
WST icon

Resona Asset Management’s West Pharmaceutical WST Stock Holding History

Resona Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Sell
29,287
-1,801
-6% -$551K 0.05% 315
2026
Q1 		$7.72M Buy
31,088
+1,060
+4% +$264K 0.04% 390
2025
Q4 		$8.27M Sell
30,028
-471
-2% -$129K 0.04% 369
2025
Q3 		$7.98M Sell
30,499
-3,060
-9% -$744K 0.04% 385
2025
Q2 		$7.34M Buy
33,559
+4,676
+16% +$1,000K 0.04% 411
2025
Q1 		$6.45M Buy
28,883
+1,563
+6% +$431K 0.04% 398
2024
Q4 		$8.99M Buy
27,320
+194
+0.7% +$61.1K 0.05% 320
2024
Q3 		$8.22M Buy
27,126
+1,456
+6% +$446K 0.05% 343
2024
Q2 		$8.45M Buy
25,670
+98
+0.4% +$34.6K 0.05% 328
2024
Q1 		$10.1M Buy
+25,572
New +$9.46M 0.06% 303

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Resona Asset Management's WST Position: Q2 2026 in Review

Resona Asset Management reduced its West Pharmaceutical (WST) stake by 5.8% in Q2 2026, selling an estimated $551K and leaving 29,287 shares worth $10.5M. The position accounts for 0.05% of the portfolio, ranked #315.

Resona Asset Management first reported a position in WST in Q1 2024 and has held it in 10 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Resona Asset Management held 29,287 shares of West Pharmaceutical worth $10.5M as of Q2 2026.
  • Resona Asset Management sold 1,801 West Pharmaceutical shares in Q2 2026, an estimated $551K.
  • West Pharmaceutical made up 0.05% of Resona Asset Management's portfolio in Q2 2026, its #315 holding.
  • Resona Asset Management first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.